title: [Rhabdomysarcoma and combined treatment in oral and maxillofacial regions].
abstract: OBJECTIVE
  To study the treatment outcome of rhabdomysarcoma(RMS).
  
  
  METHODS
  74 cases of RMS with definite pathologic diagnosis treated in our department during the past 20 years were investigated. The relationship between the therapy and prognosis was analyzed.
  
  
  RESULTS
  52 cases among the 74 patients received different surgical treatment and post-operative radiotherapy. 22 cases received radiotherapy or chemoradiotherapy without surgical treatment. The survival rates demonstrated great differences depending on the different clinical stages and therapy.
  
  
  CONCLUSIONS
  The combined therapy including radiotherapy after surgical treatment may increase 5-year survival rate.
authors.affiliation: Dept. of Oral and Maxillofacial Surgery, West China College of Stomatology, Sichuan University, Chengdu 610041, China.
authors.forename: Ge
authors.initials: G
authors.lastname: Feng
authors.forename: Da-zhang
authors.initials: DZ
authors.lastname: Wang
authors.forename: Guang-yong
authors.initials: GY
authors.lastname: Zheng
authors.forename: Jia
authors.initials: J
authors.lastname: He
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007573:Jaw Neoplasms / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D018714:Radiotherapy, Adjuvant; D012208:Rhabdomyosarcoma / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D018233:Rhabdomyosarcoma, Embryonal / Q000473:pathology / Q000601:surgery / Q000628:therapy; D015996:Survival Rate; D016896:Treatment Outcome